Detalhe da pesquisa
1.
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Br J Cancer
; 125(2): 190-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824476
2.
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Hepatology
; 71(1): 164-182, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206197
3.
Molecular therapies for HCC: Looking outside the box.
J Hepatol
; 72(2): 342-352, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954496
4.
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma.
Hepatology
; 67(3): 1132-1149, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862760
5.
Astonishing Evolution in Oropharyngeal Cancer with Immunotherapy: A Case Report.
Cancer Invest
; 37(10): 531-534, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31619066
6.
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
Liver Int
; 39(8): 1468-1477, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963691
7.
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.
Br J Cancer
; 118(2): 181-188, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29161241
8.
New trials and results in systemic treatment of HCC.
J Hepatol
; 69(2): 525-533, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653122
9.
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 107(1): 24-31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518779
10.
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Oncol
; 18(3): 323-335, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131786
11.
Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis.
Clin Sci (Lond)
; 131(1): 27-36, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803295
12.
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Br J Cancer
; 125(3): 465, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079081
13.
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Acta Oncol
; 55(9-10): 1168-1174, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27333436
14.
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
Hepatology
; 59(6): 2228-37, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443104
15.
Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.
Invest New Drugs
; 33(6): 1206-16, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377590
16.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Lancet Oncol
; 15(8): 819-28, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852116
17.
Stromal expression of SPARC in pancreatic adenocarcinoma.
Cancer Metastasis Rev
; 32(3-4): 585-602, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690170
18.
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.
Oncologist
; 19(4): 394-402, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652387
19.
Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy.
Ann Surg Oncol
; 21(9): 3077-83, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24743912
20.
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.
Invest New Drugs
; 32(5): 1028-35, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748335